Our results indicate that the cardiac-specific overexpression of GDF11 can improve DCM symptoms by reducing myocardial cell death and fibrosis, which is consistent with its function in promoting angiogenesis in diabetes [44]. This evidence concerns the gene GDF11 and diabetes mellitus.